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Purpose: The purpose of this study was to characterize the natural history of meibomian gland morphogenesis in the
mouse.
Methods: Embryonic (E) and post natal (P) C57Bl/6 mouse pups were obtained at E18.5, P0, P1, P3, P5, P8, P15, and
P60. Eyelids were fixed and processed for en bloc staining with Phalloidin/DAPI to identify gland morphogenesis, or
frozen  for  immunohistochemistry  staining  with  Oil  red  O  (ORO)  to  identify  lipid  and  antibodies  specific  against
peroxisome proliferator-activated receptor gamma (PPARγ) to identify meibocyte differentiation. Samples were then
evaluated using a Zeiss 510 Meta laser scanning confocal microscope or Nikon epi-fluorescent microscope. Tissues from
adult mice (2 month-old) were also collected for western blotting.
Results: Meibomian gland morphogenesis was first detected at E18.5 with the formation of an epithelial placode within
the fused eyelid margin. Invagination of the epithelium into the eyelid was detected at P0. From P1 to P3 there was
continued extension of the epithelium into the eyelid. ORO and PPARγ staining was first detected at P3, localized to the
central core of the epithelial cord thus forming the presumptive ductal lumen. Ductal branching was first detected at P5
associated with acinar differentiation identified by ORO and PPARγ staining. Adult meibomian glands were observed by
P15. Western blotting of meibomian gland proteins identified a 50 kDa and a 72 kDa band that stained with antibodies
specific to PPARγ.
Conclusions: We have demonstrated that meibomian gland development bears distinct similarities to hair development
with the formation of an epithelial placode and expression of PPARγ co-incident with lipid synthesis and meibocyte
differentiation.
Meibomian  glands  are  greatly  enlarged  modified
sebaceous glands without a hair follicle [1] and as a skin
appendage, their development is thought to share similarity
with hair and sebaceous gland morphogenesis in the skin.
During development of pilosebeaceous units, mesenchymal-
epithelial interactions at embryonic day 14.5 (E14.5) lead to
the  formation  of  an  ectodermal-epithelial  placode  that
progressively undergoes proliferation and growth to form hair
follicles that break the skin surface after birth [2]. Sebaceous
gland precursors appear to form along the upper segment of
the hair follicle toward the end of embryogenesis and are
characterized by the expression of peroxisome proliferator-
activated receptor gamma (PPARγ) and the synthesis of lipid
[3].  PPARs  play  critical  roles  in  cell  proliferation,
differentiation, and apoptosis [4]. They are implicated in fetal
maturation  of  murine  epidermis,  regulating  keratinocyte
differentiation, and the morphogenesis of skin appendages
including hair follicles and sebaceous glands. The PPARγ
isoform is the most studied receptor and is thought to be a key
regulator of adipogenesis and adipocyte differentiation [5,6].
PPARγ is also required for the differentiation of the sebaceous
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gland [7] and has been shown to be present in mouse and
human skin sebaceous glands in vivo [8].
By comparison, little is known about meibomian gland
development [9,10] and the most extensive study, reported by
Andersen, et al. [11], focuses on the human meibomian gland.
More importantly, no studies have reported on the expression
of  PPARγ  during  meibomian  gland  development  and  its
association with lipidogenesis.
Recently, a role for PPARγ in meibomian gland function
was hypothesized based on findings that PPARγ localization
undergoes  specific  age-related  changes  in  older  mouse
meibomian glands [12]. In young mice (<6 months of age),
PPARγ is localized in small vesicles within the cytoplasm and
the  nucleus  that  is  associated  with  a  high  meibocyte
proliferation  index.  Aging  mice  (>1  year  of  age)  show
primarily  a  nuclear  localization  that  is  associated  with
decreased  meibocyte  proliferation  and  meibomian  gland
atrophy. Overall, these findings suggest that altered PPARγ
receptor signaling in older mice may control changes in cell
cycle entry/proliferation, lipid synthesis and gland atrophy
during aging that may underlie age-related meibomian gland
dysfunction.
In this report we provide evidence that meibomian gland
development bears distinct similarities to sebaceous gland
development  and  that  PPARγ  expression  coincides  with
Molecular Vision 2010; 16:1132-1140 <http://www.molvis.org/molvis/v16/a125>
Received 27 April 2010 | Accepted 11 June 2010 | Published 18 June 2010
© 2010 Molecular Vision
1132lipogenesis  and  meibocyte  differentiation.  Overall  these
findings  support  the  hypothesis  that  PPARγ  is  a  major
regulator of meibomian gland function.
METHODS
Animals: C57Bl/6 mice were used in this study. Embryonic
(E) and postnatal (P) mouse pups were obtained at E18.5, P0,
P1, P3, P5, P8, P15, and P60. Four mice were sacrificed at
each time point.
Confocal microscopy: Eyelids from E18.5, P0, P3, P5, P8, and
P15  were  dissected  and  fixed  in  4%  paraformaldehyde
overnight at 4 °C. Samples were then washed 2 times for 30
min each with 50% TD buffer (0.5% DMSO, 0.5% Triton X,
2.5% Dextran 40 in PBS, PH 7.4) at 4 °C. Tissue was then
stained en bloc with Rhodamine Phalloidin (dilution 1:20 in
50% TD buffer; Molecular Probes, Invitrogen, Carlsbad, CA)
and  DAPI  (4',6-diamidino-2-phenylindole  nuclei  stain,
dilution  1:1,000;  Molecular  Probes,  Invitrogen,  Carlsbad,
CA) overnight on a rocker at 4 °C. The next day, samples were
washed with 50% TD buffer, 3 times, 30 min each, transferred
to PBS, and scanned using a confocal microscope (LSM 510;
Carl Zeiss MicroImaging, Thornwood, NY) using 543 nm and
633 nm lasers under a 40× oil objective.
Inmunohistochemistry:  Eyelids  were  fixed  in  2%  PFA
overnight, placed in 15% sucrose for 4 h and then transferred
to 30% sucrose overnight. Lids were embedded in Tissue-
Tek® embedding medium for frozen
tissue (Sakura Finetek USA, Inc, Torrance, CA), frozen in
liquid nitrogen and blocks stored at −80 °C until sectioned on
a cryostat. Cryosections (8 μm thick) were then cut mounted
on glass slides, and either stained for Oil Red O (ORO, Sigma-
Aldrich, St. Louis, MO) or with antibodies to PPARγ. Sections
were  stained  with  ORO  by  first  rinsing  in  PBS  and  then
incubating in 0.5% ORO solution for 10 min. Sections were
then rinsed with PBS and counterstained with hematoxylin.
For  immunostaining,  tissue  sections  were  rehydrated
with PBS, placed in acetone for 3 min and then re-hydrated in
PBS. Sections were then blocked with 1% BSA in PBS for 30
min at 37 °C and then stained with rabbit anti-PPARγ (1:50;
Abcam, Cambridge, MA) for 1 h at 37 °C. Sections were then
washed with PBS, stained with FITC conjugated goat anti-
rabbit IgG (dilution 1:200; Invitrogen, Carlsbad, CA) for 1 h
at 37 °C and then counterstained with DAPI. For negative
controls, primary antibodies were omitted. The samples were
then  evaluated  and  imaged  using  a  Nikon  Eclipse  E600
fluorescence microscope.
Western blotting: Eyelids from P60 mice were removed and
meibomian glands dissected from both the upper and lower
eye lids. Tissue was weighed and 39 mg of meibomian glands
from  5  mice  were  then  placed  in  0.5  ml  of
Radioimmunoprecipitation assay buffer (RIPA buffer, 25 mM
Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium
deoxycholate, 0.1% SDS) containing protease inhibitor and
phosphatase inhibitor. Tissue was centrifuged at 5,000× g for
20 min and the supernatant was collected. Total protein was
then measured using the RC DC Protein Assay (Bio-Rad
Figure 1. Confocal images using actin
(red) and nuclei (DAPI, cyan) staining
of  eyelids  at  different  time  points  of
meibomian  gland  morphogenesis.  At
E18.5 (A), we observed the formation of
an  epithelial  condensation  (asterisk)
within the fused lid margin. Epithelial
placodes in the superior and inferior lids
also  appeared  opposite  to  each  other,
and were associated with condensation
of  mesenchyme  as  detected  by  cell
alignment and increased actin staining
of mesenchyme directly adjacent to the
placode  (arrows).  At  P0  (B),  we
observed  an  epidermal  invagination
(arrow) that undergoes proliferation and
maturation  with  progressive
enlargement and elongation adopting a
tubular shape at P1 and P3 (C and D,
respectively).
Molecular Vision 2010; 16:1132-1140 <http://www.molvis.org/molvis/v16/a125> © 2010 Molecular Vision
1133Laboratories, Hercules, CA). For comparison, samples from
white and brown fat were also obtained and protein collected.
White and brown fat tissue was frozen in liquid nitrogen and
placed in 1 ml of RIPA buffer containing protease inhibitor
and phosphatase inhibitor. The tissue samples were sonicated,
then centrifuged at low speed 1,500× g for 5 min at 4 °C to
obtain the supernatant. The supernatant was centrifuged again
at 4 °C under the “Fast Cool” function of the centrifuge.
Samples were run on 10% SDS PAGE and the proteins were
transferred to PVDF membrane via iBlot Gel Transfer Device
(Invitrogen). The blot was then blocked using 5% non-fat dry
milk in TBS-T (0.2% Tween-20). Following blocking, the blot
was  immunostained  using  antibodies  to  PPARγ  (1:500
Dilution) and rinsed with TBS-T (0.2% Tween-20). The blot
was  then  incubated  with  goat  anti-rabbit  IgG  (H+L)  HRP
(Dilution  1:2,500;  Thermo  Scientific,  Rockford,  IL)  and
rinsed with TBS-T (0.2% Tween-20). To visualize the bands,
the  blot  was  incubated  with  SuperSignal  West  Pico
Chemiluminescent Substrate (Thermo Scientific, Rockford,
IL) and detected using photographic film.
RESULTS
Meibomian  gland  morphogenesis:  Meibomian  gland
development appeared to start at E18.5 (Figure 1A) with the
formation of an epithelial placode (Figure 1A; asterisk) within
the fused eyelid margin epithelium. Epithelial placodes in the
superior and inferior lids also appeared to form in tandem,
immediately opposite to each other, and were associated with
condensation of mesenchyme as detected by cell alignment
and increased actin staining of mesenchyme directly adjacent
to the placode (Figure 1A; arrows). At birth (P0, Figure 1B),
the epithelial invagination into the eyelid mesenchyme was
first detected and appeared to form a solid cord with no clear
lumen  (Figure  1B,  arrow)  and  with  more  prominent
condensation  of  mesenchyme  surrounding  the  epithelial
invagination.  Progressive  lengthening  of  the  invaginating
epithelial cord was detected from P1 (Figure 1C) to P3 (Figure
1D) with little additional morphogenetic changes.
At higher magnification, developing meibomian glands
at P3 appeared to be comprised of a cord of epithelium with
a bordering basal cell layer and a two-three cell suprabasal
cell  layer  within  the  inner  core  at  the  distal  end  of  the
developing  meibomian  gland  (Figure  2A,  arrow).  At  the
proximal end of the developing gland there appeared to be a
Figure 2. Nuclei staining (DAPI) at P3
and P5. At P3 (A and B), meibomian
glands appeared to be comprised of a
cord  of  epithelium  with  a  bordering
basal  cell  layer  and  a  two-three  cell
suprabasal  cell  layer  within  the  inner
core at the distal end of the developing
meibomian  gland  (A,  arrow).  At  the
proximal  end  there  appeared  to  be  a
reduction of the number of cells within
the inner core of the developing duct
(B,  arrow).  By  P5  (C  and  D),  early
branching of the invaginating epithelial
cord  was  observed  (arrows).
Additionally,  there  appeared  to  be
enlargement of cells within the central
cord of the epithelium (asterisk).
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1134reduction of the number of cells within the inner core of the
developing duct (Figure 2B, arrow). By P5, early branching
of the invaginating epithelial cord was detected at both the
distal (Figure 2C, arrow) and proximal end (Figure 2D, arrow)
Figure 3. Confocal images using actin
(red) and nuclei (DAPI, cyan) staining
of eyelids at P8 and P15. At P8 (A),
developing meibomian glands showed
distinct differentiation into ductal and
acinar regions. Within the ductal region,
basal epithelial cells along with a single
layer of suprabasal cells appear to line a
more central region containing enlarged
epithelial cells that lacked actin staining
(asterisk). Within the acinar region, the
developing  meibomian  gland  duct
branched  into  multiple  ductules  that
appeared to lack any cellular contents
(arrows) and terminated into developing
acini. At P15 (B), the meibomian glands
appear  to  obtain  an  adult  meibomian
gland morphology.
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1135of the developing gland. Additionally, there appeared to be
enlargement of cells within the central cord of the epithelium
(Figure 2C,D, asterisk). By P8 the developing meibomian
glands showed distinct differentiation into ductal and acinar
regions (Figure 3A). Within the ductal region, basal epithelial
cells along with a single layer of suprabasal cells appeared to
line a more central region containing enlarged epithelial cells
that lacked actin staining (Figure 3A, asterisk). Within the
acinar region, the developing meibomian gland duct branched
into  multiple  ductules  that  appeared  to  lack  any  cellular
contents (arrows) and terminated into developing acini. By
P15,  the  meibomian  glands  appeared  to  obtain  a  normal
meibomian gland morphology (Figure 3B).
Meibocyte  differentiation  and  lipid  synthesis:  Meibocyte
differentiation was evaluated by staining for PPARγ using a
rabbit polyclonal antibody directed against a synthetic peptide
derived  from  residues  50–150  of  human  PPARγ.
Immunostaining of meibomian glands from adult, P60 mice
showed  nuclear  and  extra-nuclear  staining  of  the  plasma
membrane and intracellular structures, possibly microsomes
(Figure 4A). Staining of white fat and brown fat (Figure 4B,C,
respectively)  showed  predominantly  nuclear  staining.
Western blotting of meibomian gland protein from adult mice
with  PPARγ  antibodies  identified  a  50  kDa  protein  band
(Figure 4D, lane 1) that was also present in extracts from white
fat and brown fat (Figure 4D, lane 2 and 3, respectively). An
additional band at 72 kDa was also identified that might be
related to post-translational modifications of the protein.
During morphogenesis, staining for PPARγ was negative
at  E18.5  and  at  birth  (P0)  (Figure  5A,B,  respectively).
PPARγ staining was first detected at P3 within the central
region of the invaginating epithelium (Figure 5C, arrow); the
same  time  that  sebaceous  glands  appeared  to  stain  for
PPARγ  (arrowhead).  PPARγ  staining  appeared  to
progressively increase at P5 and P8 as the gland continued to
develop  (Figure  5D,E,  arrow),  however  the  localization
appeared to be both within and along the proximal end of
developing meibomian gland duct. By P15, PPARγ staining
was  localized  to  the  meibomian  gland  acini  (Figure  5F,
arrows) that bordered the central ductal epithelium, which was
negative for PPARγ (Figure 5F, asterisk).
Association  of  meibocyte  differentiation  with  lipid
production was assessed by ORO staining and showed that
eyelids were negative for lipid at both E18.5 and P0 (Figure
6A,B, arrow). Lipid was first detected at P3 and was limited
to the central region of the invaginating epithelium (Figure
6C, arrow); the same region stained by antibodies to PPARγ.
At P5 and P8, ORO staining continued to be limited to the
inner core of the developing duct and ductules (Figure 6D,E,
respectively). After eyelid opening at P15, ORO was present
in the acini of the mature meibomian glands (Figure 6F).
DISCUSSION
To our knowledge, reports covering the development of the
meibomian gland are fragmentary and limited, for the most
part, to the appearance of tarsal glands during eyelid opening
Figure  4.  PPARγ  (Green)  and  nuclei
(DAPI,  red)  staining  of  meibomian
glands, white fat, and brown fat from
adult,  P60  mice.  In  the  meibomian
glands  (A),  nuclear  and  extra-nuclear
staining of the plasma membrane and
intracellular  structures,  possibly
microsomes were detected. Staining of
white  fat  and  brown  fat  (B  and  C,
respectively)  showed  predominantly
nuclear  staining.  Western  blotting  of
meibomian gland protein with PPARγ
antibodies identified a 50 kDa protein
band (D, lane 1) that was also present in
extracts from white fat and brown fat
(D, lane 2 and 3, respectively). Note that
the  meibomian  gland,  white  fat  and
brown fat all showed a second band with
a molecular weight of 72 kDa that may
represent  post-translational
modifications of PPARγ.
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1136[9,10]. The most extensive study reported by Andersen et al.
[11]  and  also  discussed  by  Knop  et  al.  [13]  reports  that
meibomian  glands  in  the  human  eyelid  initially  form  as
epithelial cords that develop following eyelid fusion. Lateral
branching  of  the  epithelial  cords  then  form  acini  later  in
development. Lipid synthesis was also noted to occur within
the  acini  and  the  epithelial  invagination  thus  forming  the
central ductal system of the glands.
Our results with confocal microscopy support and extend
these  observations  and  indicate  that  meibomian  gland
development in the mouse is initiated around E18.5 with the
formation  of  an  epithelial  placode  and  mesenchymal
condensation,  similar  to  that  observed  in  hair  follicle
development [14,15]. Invagination of the epithelium into the
developing mesenchyme then continues from birth to about
P3 with initial branching of the epithelial cord detected at P5.
By  P8  the  developing  meibomian  gland  shows  extensive
ductal  branching  and  the  formation  of  distinct  acini  with
mature meibomian glands present by P15 or eyelid opening.
During  meibomian  gland  development,  PPARγ
expression was first detected at P3, before epithelial branching
and the formation of distinct acini. PPARγ expression was
also  localized  to  the  central  core  of  the  invaginating
epithelium, the same region where lipid synthesis was first
detected. Interestingly, PPARγ expression remained localized
to the developing duct and acinar regions from P5 to P8, but
was restricted to the acini by P15. Overall, these findings
suggest that PPARγ plays an important role in meibomian
gland  morphogenesis,  meibocyte  differentiation  and  lipid
synthesis.
Figure  5.  PPARγ  (green)  and  nuclei
(DAPI, red) staining during meibomian
gland morphogenesis. At E18.5 (A) and
P0 (B), PPARγ staining of the epithelial
placode  was  negative.  At  P3  (C),
PPARγ was first detected in the lumen
of the developing gland and increased
progressively as the gland continued to
develop at P5 (D) and P8 (E). At P15
(F), PPARγ staining was limited to the
acini (arrows) or the terminal regions of
the  branching  ductules  (the  asterisk
shows a well developed central duct at
P15).
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1137Interestingly, western blots of adult meibomian gland
tissue extracts identified a low and high molecular weight
PPARγ  protein.  Message  for  PPARγ  can  be  alternatively
spliced to a 475 amino acid (γ1) and 505 amino acid (γ2)
isoform of approximately 50 kDa. PPARγ also contains a
consensus serine phosphorylation site at S112 that may be
associated with decreased transcriptional activity [16,17] and
two sumoylation sites, K107 and K395, that may be linked to
nuclear-cytoplasmic transport, apoptosis, and transcriptional
regulation  [18].  Since  sumoylation  covalently  attaches
sumo-1 or sumo-2/3, each approximately 11 kDa, it is likely
that the high molecular weight PPARγ identified in this study
represents a post translational sumoylation. Clearly, future
studies  identifying  the  post  translational  modifications  of
PPARγ will be important to understanding the role of this
receptor in regulating meibomian gland function.
Additionally,  PPARγ  contains  an  NH2-terminal
transactivation domain (residues 30–136), a DNA binding
domain (residues 136–140), and a COOH-terminal ligand-
binding  domain  (residues  204–505)  containing  a  ligand-
dependent  transactivation  function  [19].  Interestingly,
PPARγ functions as a “molecular switch” and can recruit
corepressors, N-CoR and SMRT, when unliganded PPARγ
binds to some target genes promoters, which upon ligand
binding recruits co-activators, SRC1/CBP and TRAP/DRIP/
ARC complexes [20].
Importantly, PPARγ has been shown to play a critical role
in both adipogenesis and sebaceous gland development with
mice  chimeric  for  PPARγ  null  cells  showing  little  or  no
Figure 6. ORO staining for lipid during
meibomian  gland  development  at
different  time  points.  Consistent  with
PPARγ,  ORO  staining  was  absent  at
E18.5 (A) and P0 (B). Lipid production
was first detected at P3 (C) within the
central region of the developing duct. At
P5  (D)  and  P8  (E),  ORO  staining
continued to be limited to the inner core
of  the  developing  duct.  After  eyelid
opening at P15 (F), ORO was present in
the acini of the mature gland.
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1138contribution to the formation of fat or sebaceous glands [7].
Additionally, PPARγ agonists, such as thiazolidinediones and
rosiglitazone, increase sebum production in diabetic patients
and  lipid  synthesis  in  sebocyte  cell  cultures,  respectively
[21]. Recent studies also suggest that there can be distinct
gender differences in the transcriptional activity of the PPAR
gene [22] and there is at least one report suggesting that
androgens  and  PPAR  ligands  may  act  synergistically  to
regulate  lipid  synthesis  in  cultured  sebocytes  [23].  If
transferable to the meibomian gland, these findings suggest
that understanding the role of PPARγ in meibomian gland
function may provide important insights into the pathogenesis
of meibomian gland dysfunction. Further work studying the
modulation of PPARγ expression or activity will be needed to
clarify  the  role  PPARγ  in  regulating  meibum  production.
More interestingly, selective modulation of PPARγ activity
may be a potential therapeutic strategy for the treatment of dry
eye syndrome and meibomian gland dysfunction.
In  summary,  we  have  demonstrated  that  meibomian
gland development starts with the formation of an epithelial
placode similar to that observed for the development of the
pilosebaceous  unit.  Development  then  proceeds  with
invagination of the epithelium into the eyelid mesenchyme
forming a solid cord. By post natal day 3, the adipogenic
nuclear receptor PPARγ is first expressed within the epithelial
cord  in  association  with  lipid  synthesis,  thus  forming  the
presumptive ductal lumen, and later, the nascent acini at post
natal  day  5.  Meibomian  glands  appear  to  be  completely
formed by the time of eyelid opening with PPARγ restricted
to the acinar compartment. Overall, PPARγ appears to be a
molecular marker of meibocyte differentiation.
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